USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES

The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PIAGGIO, ELIANE, SAADOUN, DAVID, ROSENZWAJG, MICHELE, BENSIMON, GILBERT, CACOUB, PATRICE, KLATZMANN, DAVID, BERNARD, CLAUDE
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PIAGGIO, ELIANE
SAADOUN, DAVID
ROSENZWAJG, MICHELE
BENSIMON, GILBERT
CACOUB, PATRICE
KLATZMANN, DAVID
BERNARD, CLAUDE
description The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2683395A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2683395A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2683395A13</originalsourceid><addsrcrecordid>eNrjZDAMDXZV8HdT8PEPV3DxB7I9fXSNFNz8gxRCglwdQzz93BVCIgNcFQwVXDwdnVxDXIN5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CRmYWxsaWpo6ExEUoAs_EldA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES</title><source>esp@cenet</source><creator>PIAGGIO, ELIANE ; SAADOUN, DAVID ; ROSENZWAJG, MICHELE ; BENSIMON, GILBERT ; CACOUB, PATRICE ; KLATZMANN, DAVID ; BERNARD, CLAUDE</creator><creatorcontrib>PIAGGIO, ELIANE ; SAADOUN, DAVID ; ROSENZWAJG, MICHELE ; BENSIMON, GILBERT ; CACOUB, PATRICE ; KLATZMANN, DAVID ; BERNARD, CLAUDE</creatorcontrib><description>The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140115&amp;DB=EPODOC&amp;CC=EP&amp;NR=2683395A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140115&amp;DB=EPODOC&amp;CC=EP&amp;NR=2683395A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PIAGGIO, ELIANE</creatorcontrib><creatorcontrib>SAADOUN, DAVID</creatorcontrib><creatorcontrib>ROSENZWAJG, MICHELE</creatorcontrib><creatorcontrib>BENSIMON, GILBERT</creatorcontrib><creatorcontrib>CACOUB, PATRICE</creatorcontrib><creatorcontrib>KLATZMANN, DAVID</creatorcontrib><creatorcontrib>BERNARD, CLAUDE</creatorcontrib><title>USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES</title><description>The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAMDXZV8HdT8PEPV3DxB7I9fXSNFNz8gxRCglwdQzz93BVCIgNcFQwVXDwdnVxDXIN5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CRmYWxsaWpo6ExEUoAs_EldA</recordid><startdate>20140115</startdate><enddate>20140115</enddate><creator>PIAGGIO, ELIANE</creator><creator>SAADOUN, DAVID</creator><creator>ROSENZWAJG, MICHELE</creator><creator>BENSIMON, GILBERT</creator><creator>CACOUB, PATRICE</creator><creator>KLATZMANN, DAVID</creator><creator>BERNARD, CLAUDE</creator><scope>EVB</scope></search><sort><creationdate>20140115</creationdate><title>USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES</title><author>PIAGGIO, ELIANE ; SAADOUN, DAVID ; ROSENZWAJG, MICHELE ; BENSIMON, GILBERT ; CACOUB, PATRICE ; KLATZMANN, DAVID ; BERNARD, CLAUDE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2683395A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PIAGGIO, ELIANE</creatorcontrib><creatorcontrib>SAADOUN, DAVID</creatorcontrib><creatorcontrib>ROSENZWAJG, MICHELE</creatorcontrib><creatorcontrib>BENSIMON, GILBERT</creatorcontrib><creatorcontrib>CACOUB, PATRICE</creatorcontrib><creatorcontrib>KLATZMANN, DAVID</creatorcontrib><creatorcontrib>BERNARD, CLAUDE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PIAGGIO, ELIANE</au><au>SAADOUN, DAVID</au><au>ROSENZWAJG, MICHELE</au><au>BENSIMON, GILBERT</au><au>CACOUB, PATRICE</au><au>KLATZMANN, DAVID</au><au>BERNARD, CLAUDE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES</title><date>2014-01-15</date><risdate>2014</risdate><abstract>The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2683395A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T08%3A02%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PIAGGIO,%20ELIANE&rft.date=2014-01-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2683395A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true